Sort
30,917 grants matching “tumor microenvironment”
TNF-alpha-"armed" TCR vectors to enhance adoptive cell therapy for solid tumors
$647,632Theodore Scott Nowicki · University Of California Los Angeles · R37 · FY2025 · CA
Massive single cell proteomics for cancer biology
$647,510Ljiljana Pasa-Tolic · Battelle Pacific Northwest Laboratories · R01 · FY2023 · CA
Regulatory T cells in cancer therapy
$647,392Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
CTL-killing capacity and cancer stiffness in cancer immunity and therapy
$647,366Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Regulatory T cells in cancer therapy
$647,349Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
CTL-killing capacity and cancer stiffness in cancer immunity and therapy
$647,331Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Modulating the PD-1/PD-L1 checkpoint to promote antitumor activity of HER2 CAR T cells in patients with sarcoma
$647,322Meenakshi G Hegde · Baylor College Of Medicine · R01 · FY2025 · CA
Naive T cells in Cancer Immune Evasion and Immunotherapy
$647,249Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
Deciphering the role of EYA3/PP2A in triple negative breast cancer metastasis
$647,118Heide L Ford · University Of Colorado Denver · R01 · FY2025 · CA
Defining brain-body feedback loops mediating stress-induced metastasis
$646,873Mikala Egeblad · Johns Hopkins University · U01 · FY2025 · CA
Steatotic Liver Promotes Metastatic Niche: Role of Hepatic Stellate Cells
$646,739Ekihiro Seki · Cedars-Sinai Medical Center · R01 · FY2025 · CA
Inflammation and the esophageal tumor microenvironment
$646,586Anil K Rustgi · University Of Pennsylvania · U01 · FY2010 · CA
Metabolic impact on T cell-mediated cancer immunity and therapy
$646,476Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2020 · CA
Metabolic impact on T cell-mediated cancer immunity and therapy
$646,425Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
Stimulation of Tumorigenesis by NKG2D
$646,415Thomas Spies · Fred Hutchinson Cancer Research Center · R01 · FY2015 · CA
Novel immunological biomarkers ovarian cancer prognosis
$646,389Brahm H. Segal · Roswell Park Cancer Institute Corp · R01 · FY2016 · CA
Novel immunological biomarkers ovarian cancer prognosis
$646,389Brahm H. Segal · Roswell Park Cancer Institute Corp · R01 · FY2017 · CA
Novel targeted therapy for treating Ovarian Cancer
$646,388Ratna K Vadlamudi · University Of Texas Hlth Science Center · R01 · FY2023 · CA
Using MRI and circulating tumor DNA to improve the interpretation of response to immunotherapy and targeted therapy in CNS metastases
$646,356Elizabeth Gerstner · Massachusetts General Hospital · R01 · FY2024 · CA
Sexual dimorphism and the immuno-modulatory role of estrogen signaling in HNSCC
$646,344Sana D Karam · University Of Colorado Denver · R01 · FY2023 · CA
IMMUNOTHERAPY OF MELANOMA: TARGETING HELIOS IN THE TUMOR MICROENVIRONMENT FOR EFFECTOR CELL CONVERSION
$646,313Dana-Farber Cancer Institute, Inc. · · FY2017 · Department of the Army
The Oral Mycobiome and Risk of Pancreatic Cancer
$646,256Jiyoung Ahn · New York University School Of Medicine · U01 · FY2021 · CA
The impact of the dermal ECM microenvironment on cutaneous aging and cancer
$646,238Gary J. Fisher · University Of Michigan At Ann Arbor · R01 · FY2024 · AG
Mouse models of Kras-mutant colorectal cancer
$646,021Kevin Michael Haigis · Dana-Farber Cancer Inst · R01 · FY2020 · CA
Defining the role of seed and soil in peritoneal metastasis evolution
$645,925Kamila Naxerova · Harvard Medical School · R01 · FY2025 · CA